טוען...
Costs and Consequences of Using Interferon-γ Release Assays for the Diagnosis of Active Tuberculosis in India
BACKGROUND: There is growing concern that interferon-γ release assays (IGRAs) are being used off-label for the diagnosis of active tuberculosis (TB) disease in many high-burden settings, including India, where the background prevalence of latent TB infection is high. We analyzed the costs and conseq...
שמור ב:
| הוצא לאור ב: | PLoS One |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Public Library of Science
2015
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4412573/ https://ncbi.nlm.nih.gov/pubmed/25918999 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0124525 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|